Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

August 22, 2019

Study Completion Date

May 5, 2023

Conditions
Female InfertilityFemale Infertility Due to Ovulatory DisorderPremature Ovarian FailurePolycystic Ovary SyndromeFemale Infertility of Tubal OriginEctopic PregnancySalpingitisFemale Infertility Due to Tubal BlockFemale Infertility Due to Tubal OcclusionHydrosalpinxFemale Infertility - Cervical/VaginalFemale Infertility EndocrineEndometriosisFibroidsCongenital Uterine AnomalyInfections UterineFemale Infertility of Other Origin
Interventions
DRUG

Human Chorionic Gonadotropin (hCG)

Administration of hCG (10.000IU) for ovulation triggering

DRUG

Gonadotropins

Administration of Menotropin (hMG / FSH and LH at a 1:1 ratio) (150-225IU/day)

DRUG

GNRH-A Triptorelin

Administration of Triptorelin (0.1mg/day)

DRUG

GnRH antagonist

Administration of cetrorelix (cetrotide) or ganirelix (orgulatron) (0.25mg/day)

Trial Locations (1)

961

Lebanese University, faculty of sciences III, Tripoli

All Listed Sponsors
lead

Lebanese University

OTHER

NCT04071574 - Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility | Biotech Hunter | Biotech Hunter